From the FDA MedWatch on September 29, 2008:

An FDA analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as “Lou Gehrig’s Disease.” The FDA analysis, undertaken after the agency received a higher than expected number of reports of ALS in patients on statins, is based on data from 41 long-term controlled clinical trials. The results showed no increased incidence of the disease in patients treated with a statin compared with placebo.

The FDA is anticipating the completion of a case-control or epidemiological study of ALS and statin use. Results from this study should be available within 6-9 months. FDA is also examining the feasibility of conducting additional epidemiologic studies to examine the incidence and clinical course of ALS in patients taking statins.

Based on currently available information, health care professionals should not change their prescribing practices for statins and patients should not change their use of statins.

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Print a coupon for up to $25 off next refill.  Subject to eligibility requirements. Limit one free trial per person.  You must provide contact information and answer the 3 questions on the registration form on their website.

Get the details at  https://www.veramyst.com/optin/savings.jsp

Check out our list of coupons for this drug and others at Rx $$$.

Active ingredient(s): Iobenguane Sulfate I 123 

Dosage form: 10MCI/5ML (2MCI/ML) intravenous injection

Manufacturer: GE Healthcare

Usage: a diagnostic radiopharmaceutical agent for gamma-scintigraphy indicated for use in the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests.

Approval Date: September 19, 2008

For more information visit http://www.fda.gov/cder/foi/label/2008/22290lbl.pdf

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): Granisetron

Dosage form: 3.1 mg/24 hr extended release transdermal system

Manufacturer: Strakan

Usage: indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days.

Approval Date: September 12, 2008

For more information visit http://www.sancuso.com/Sancuso_PI.pdf

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): levetiracetam extended-release tablets

Dosage form: 500 mg extended-release tablet

Manufacturer: UCB

Usage: adjunctive therapy in the treatment of partial onset seizures in patients ? 16 years of age with epilepsy

Approval Date: September 12, 2008

For more information visit http://www.keppraxr.com/includes/pdf/Keppra_XR_Prescribing_Information.pdf

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Get a free 30-day supply of Avodart.  Complete a form and receive information by mail and your free trial voucher.  

Get the details at https://www.avodart.com/free-trial/fto.jsp 

Check out our list of coupons for this drug and others at Rx $$$.

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.